Instrumento Inactivo

Acciones Ablynx CBOE EUROPE EQUITIES

Acciones

Precio de cierre CBOE EUROPE EQUITIES Otros sitios de cotización
- ^EUR	-

Immunicum : and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies	19/11/20
AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit	15/10/18
SANOFI : a finalisé l'acquisition d'Ablynx	19/06/18
Ablynx : SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE	19/06/18
Ablynx : PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")	28/05/18

Directores	Puesto	Edad	Desde
Petrus Houwen CEO	Chief Executive Officer	-	01/04/19

Administradores	Puesto	Edad	Desde
Kristine de Sutter BRD	Director/Board Member	-	01/04/19
Pieter Oldenziel BRD	Director/Board Member	-	01/01/19

Sector

	Varia. 1 de ene.	Capi.
MODERNA, INC.	+34,14 %	51,12 mil M
IQVIA HOLDINGS INC.	-6,54 %	39,4 mil M
LONZA GROUP AG	+34,92 %	38,48 mil M
CELLTRION, INC.	-12,11 %	26,22 mil M
ICON PUBLIC LIMITED COMPANY	+12,62 %	26,36 mil M
ALNYLAM PHARMACEUTICALS, INC.	-13,43 %	20,96 mil M
UNITED THERAPEUTICS CORPORATION	+43,73 %	14,02 mil M
MEDPACE HOLDINGS, INC.	+31,81 %	12,49 mil M
BIO-TECHNE CORPORATION	-4,54 %	11,61 mil M